Although we tried to ensure mechanistically that J54 works via inhibition of the ADT-activated TLK > Nek1>ATR > Chk1 DDR pathway, we cannot rule out that the tumor regression effects that we have observed could be caused by inhibition of some other target. The gene discussed is ATR; the disease is neoplasm.